Frontiers in Pharmacology | Gastrointestinal and Hepatic Pharmacology

Correction

Published on 26 Jul 2023

Corrigendum: Revealing the mechanism of Huazhi Rougan granule in the treatment of nonalcoholic fatty liver through intestinal flora based on 16S rRNA, metagenomic sequencing and network pharmacology

in Gastrointestinal and Hepatic Pharmacology

Yingying Liu
Yingying Tan
Jiaqi Huang
Chao Wu
Xiaotian Fan
Antony Stalin
Shan Lu
Haojia Wang
Jingyuan Zhang
Fanqin Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1243304

1,395 views

Original Research

Published on 24 Jul 2023

Inulin ameliorates metabolic syndrome in high-fat diet-fed mice by regulating gut microbiota and bile acid excretion

in Gastrointestinal and Hepatic Pharmacology

Shaoxiong Huang
Shiliang Dong
Lizhen Lin
Qiming Ma
Mengping Xu
Limei Ni
Qitong Fan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1226448

4,487 views
12 citations

Systematic Review

Published on 19 Jul 2023

Non-selective beta-blockers and the incidence of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis

in Gastrointestinal and Hepatic Pharmacology

Xinyi He
Zimo Zhao
Xi Jiang
Yan Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1216059

3,365 views
10 citations

Original Research

Published on 19 Jul 2023

Neuropsychiatric disorders in chronic hepatitis C patients after receiving interferon or direct-acting antivirals: a nationwide cohort study

in Gastrointestinal and Hepatic Pharmacology

Yu Fang
Chung-Yu Chen
Hsien-Chung Yu
Pei-Chin Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1191843

1,768 views
6 citations

Review

Published on 17 Jul 2023

Proton pump inhibitors may enhance the risk of digestive diseases by regulating intestinal microbiota

in Gastrointestinal and Hepatic Pharmacology

Liang Tian
Chongfei Huang
Wenkang Fu
Long Gao
Ningning Mi
Mingzhen Bai
Haidong Ma
Chao Zhang
Yawen Lu
Jinyu Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1217306

15,621 views
23 citations

Review

Published on 13 Jul 2023

Advances in natural compound-based nanomedicine and the interaction with gut microbiota in ulcerative colitis therapy

in Gastrointestinal and Hepatic Pharmacology

Jinlan Zhang
Shuhui Sun
Huan Chen
Yifan Feng
Ying Li
Zhengqi Dong

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1197144

3,794 views
9 citations

Editorial

Published on 13 Jul 2023

Editorial: Advances in the potential treatments of gastrointestinal and liver diseases: addressing the public health burden

in Gastrointestinal and Hepatic Pharmacology

Adina Turcu-Stiolica
Maria Dimitrova
Mariana Jinga

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1253069

999 views

Retraction

Published on 07 Jul 2023

Retraction: Melatonin attenuates dysregulation of the circadian clock pathway in mice with CCl4-induced fibrosis and human hepatic stellate cells

in Gastrointestinal and Hepatic Pharmacology

Frontiers Editorial Office

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1252194

2,043 views

Correction

Published on 07 Jul 2023

Corrigendum: Metabonomic analysis of the anti-hepatic fibrosis effect of Ganlong capsules

in Gastrointestinal and Hepatic Pharmacology

ChangLing Lv
YinRui Li
Ling Ou
Jie Zhou
Fang Peng
DingYu Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1231544

1,362 views

Retraction

Published on 06 Jul 2023

Retraction: Quercetin inhibits tumorigenesis of colorectal cancer through downregulation of hsa_circ_0006990

in Gastrointestinal and Hepatic Pharmacology

Frontiers Editorial Office

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1252183

2,828 views

Review

Published on 30 Jun 2023

Role of NLRP3 inflammasome and oxidative stress in hepatic insulin resistance and the ameliorative effect of phytochemical intervention

in Gastrointestinal and Hepatic Pharmacology

Isabela Jesus de Deus
Ana Flávia Martins-Silva
Miliane Martins de Andrade Fagundes
Sílvia Paula-Gomes
Fernanda Guimarães Drummond e Silva
Larissa Leandro da Cruz
Aline Rezende Ribeiro de Abreu
Karina Barbosa de Queiroz

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1188829

4,772 views
12 citations

Original Research

Published on 27 Jun 2023

Oat beta-glucan reduces colitis by promoting autophagy flux in intestinal epithelial cells via EPHB6-TFEB axis

in Gastrointestinal and Hepatic Pharmacology

Mingyang Xu
Fangmei Ling
Junrong Li
Yidong Chen
Shuang Li
Yiyu Cheng
Liangru Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1189229

4,615 views
6 citations

Review

Published on 21 Jun 2023

The regulatory role of bile acid microbiota in the progression of liver cirrhosis

in Gastrointestinal and Hepatic Pharmacology

Feng Zhu
Shudan Zheng
Mei Zhao
Fan Shi
Lihong Zheng
Haiqiang Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1214685

4,273 views
9 citations

Original Research

Published on 14 Jun 2023

A bibliometric study on the utilization of lenvatinib in hepatocellular carcinoma (2014–2022)

in Gastrointestinal and Hepatic Pharmacology

Cong-Cong Wang
Cai-Yan Yu
Jing Zhang
Rui Wang
Xiang-Shuo Kong

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1159286

2,411 views

Original Research

Published on 14 Jun 2023

Curcumin alleviates 1-methyl- 4-phenyl- 1,2,3,6-tetrahydropyridine- induced Parkinson’s disease in mice via modulating gut microbiota and short-chain fatty acids

in Gastrointestinal and Hepatic Pharmacology

Benchi Cai
Lifan Zhong
Qitong Wang
Wendi Xu
Xi Li
Tao Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1198335

4,950 views
18 citations

Review

Published on 13 Jun 2023

Hepatotoxic mechanism of cantharidin: insights and strategies for therapeutic intervention

in Gastrointestinal and Hepatic Pharmacology

Dian Jin
Na-Na Huang
Jing-Xia Wei

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1201404

3,375 views
12 citations